Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
2.845
-0.140 (-4.69%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Processa Pharmaceuticals Employees
Processa Pharmaceuticals had 12 employees as of December 31, 2025. The number of employees increased by 2 or 20.00% compared to the previous year.
Employees
12
Change (1Y)
2
Growth (1Y)
20.00%
Revenue / Employee
n/a
Profits / Employee
-$1,130,320
Market Cap
7.57M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 41 |
| Genprex | 13 |
| TransCode Therapeutics | 12 |
| MetaVia | 8 |
| Immuron | 7 |
| Indaptus Therapeutics | 5 |
| Acurx Pharmaceuticals | 4 |
| Creative Medical Technology Holdings | 4 |
PCSA News
- 3 months ago - Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study - GlobeNewsWire
- 4 months ago - Why Is Small-Cap Processa Pharmaceuticals Stock Rallying After Breast Cancer Trial Data? - Benzinga
- 4 months ago - Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer - GlobeNewsWire
- 6 months ago - Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025 - GlobeNewsWire
- 9 months ago - Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies - GlobeNewsWire
- 10 months ago - Processa Pharmaceuticals Transcript: Status Update - Transcripts
- 10 months ago - Processa Pharmaceuticals Provides Portfolio and Business Update - GlobeNewsWire